Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism (Homo sapiens)
From WikiPathways
Description
The biosynthesis of steroid hormones is a difficult process in which Cholesterol is transformed into mineralocorticoids, glucocorticoids and sex hormones via a series of hydroxylation, oxidation and reduction steps. To better understand the molecular level of sexual organ maturation in humans, the classical pathway and the alternative pathway of this process are produced. The pathways produce the main steroid hormones in humans, namely Progestogen, Corticosteroids, Androgens and Estrogens.
The classical pathway is meant to produce an important steroid called Androgen, which is a synthetic steroid hormone that regulates sexual development and the maintenance of the male sex organs via binding to androgen receptors.
For more information and details about Androgens and the diseases linked with this molecular pathway, please visit Chapter 37 of the book of Blau (ISBN 978-3-642-40337-8)
Quality Tags
Ontology Terms
Bibliography
View all... |
- Yong AB, Montalto J, Pitt J, Oakes S, Preston T, Buchanan C; ''Corticosterone methyl oxidase type II (CMO II) deficiency: biochemical approach to diagnosis.''; Clin Biochem, 1994 PubMed Europe PMC Scholia
- Makridakis NM, di Salle E, Reichardt JK; ''Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.''; Pharmacogenetics, 2000 PubMed Europe PMC Scholia
- Parsa AA, New MI; ''Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.''; J Steroid Biochem Mol Biol, 2017 PubMed Europe PMC Scholia
- Kim SM, Rhee JH; ''A case of 17 alpha-hydroxylase deficiency.''; Clin Exp Reprod Med, 2015 PubMed Europe PMC Scholia
- Blau, Nenad, Duran, Marinus, Gibson, K, Michael, Dionisi-Vici, Carlo; ''Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Disease'''; ISBN 978-3-64240337-8, 2014
- Baquedano MS, Ciaccio M, Marino R, Perez Garrido N, Ramirez P, Maceiras M, Turjanski A, Defelipe LA, Rivarola MA, Belgorosky A; ''A novel missense mutation in the HSD3B2 gene, underlying nonsalt-wasting congenital adrenal hyperplasia. new insight into the structure-function relationships of 3β-hydroxysteroid dehidrogenase type II.''; J Clin Endocrinol Metab, 2015 PubMed Europe PMC Scholia
- Unal E, TaÅŸ FF, Demir V, Onay H, Haspolat YK; ''Aromatase Deficiency due to a Novel Mutation inCYP19A1Gene''; J Clin Res Pediatr Endocrinol, 2018 PubMed Europe PMC Scholia
- Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ; ''11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.''; Proc Natl Acad Sci U S A, 1997 PubMed Europe PMC Scholia
- Katsumata N; ''Cholesterol Side-Chain Cleavage Enzyme (SCC) Deficiency.''; Clin Pediatr Endocrinol, 2007 PubMed Europe PMC Scholia
- Funder JW; ''Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance.''; Annu Rev Med, 1997 PubMed Europe PMC Scholia
- Burkhard FZ, Parween S, Udhane SS, Flück CE, Pandey AV; ''P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.''; J Steroid Biochem Mol Biol, 2017 PubMed Europe PMC Scholia
- HAYANO M, DORFMAN RI; ''On the mechanism of the C11 beta-hydroxylation of steroids.''; J Biol Chem, 1954 PubMed Europe PMC Scholia
- Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN; ''Progesterone resistance in endometriosis: origins, consequences and interventions.''; Acta Obstet Gynecol Scand, 2017 PubMed Europe PMC Scholia
- Kostyrko A, Antkowiak J, Warenik-Szymankiewicz A, Trzeciak WH; ''[The importance of DNA analysis in the diagnosis of steroid 5-alpha-reductase deficiency].''; Ginekol Pol, 1994 PubMed Europe PMC Scholia
- Kaur J, Casas L, Bose HS; ''Lipoid congenital adrenal hyperplasia due to STAR mutations in a Caucasian patient.''; Endocrinol Diabetes Metab Case Rep, 2016 PubMed Europe PMC Scholia
- Funder JW; ''Apparent mineralocorticoid excess.''; J Steroid Biochem Mol Biol, 2017 PubMed Europe PMC Scholia
- Carvajal CA, Gonzalez AA, Romero DG, González A, Mosso LM, Lagos ET, Hevia Mdel P, Rosati MP, Perez-Acle TO, Gomez-Sanchez CE, Montero JA, Fardella CE; ''Two homozygous mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess.''; J Clin Endocrinol Metab, 2003 PubMed Europe PMC Scholia
- Palmisano BT, Zhu L, Stafford JM; ''Role of Estrogens in the Regulation of Liver Lipid Metabolism.''; Adv Exp Med Biol, 2017 PubMed Europe PMC Scholia
- Mendonca BB, Gomes NL, Costa EM, Inacio M, Martin RM, Nishi MY, Carvalho FM, Tibor FD, Domenice S; ''46,XY disorder of sex development (DSD) due to 17β-hydroxysteroid dehydrogenase type 3 deficiency.''; J Steroid Biochem Mol Biol, 2017 PubMed Europe PMC Scholia
- Pascoe L, Curnow KM, Slutsker L, Rösler A, White PC; ''Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency.''; Proc Natl Acad Sci U S A, 1992 PubMed Europe PMC Scholia
- Mindnich R, Haller F, Halbach F, Moeller G, Hrabé de Angelis M, Adamski J; ''Androgen metabolism via 17beta-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme.''; J Mol Endocrinol, 2005 PubMed Europe PMC Scholia
- Fardella CE, Miller WL; ''Molecular biology of mineralocorticoid metabolism.''; Annu Rev Nutr, 1996 PubMed Europe PMC Scholia
- Kuribayashi I, Nomoto S, Massa G, Oostdijk W, Wit JM, Wolffenbuttel BH, Shizuta Y, Honke K; ''Steroid 11-beta-hydroxylase deficiency caused by compound heterozygosity for a novel mutation, p.G314R, in one CYP11B1 allele, and a chimeric CYP11B2/CYP11B1 in the other allele.''; Horm Res, 2005 PubMed Europe PMC Scholia
- Ghosh D, Griswold J, Erman M, Pangborn W; ''Structural basis for androgen specificity and oestrogen synthesis in human aromatase.''; Nature, 2009 PubMed Europe PMC Scholia
- Strushkevich N, MacKenzie F, Cherkesova T, Grabovec I, Usanov S, Park HW; ''Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system.''; Proc Natl Acad Sci U S A, 2011 PubMed Europe PMC Scholia
- Pang S, Wang W, Rich B, David R, Chang YT, Carbunaru G, Myers SE, Howie AF, Smillie KJ, Mason JI; ''A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.''; J Clin Endocrinol Metab, 2002 PubMed Europe PMC Scholia
- Lawson AJ, Walker EA, Lavery GG, Bujalska IJ, Hughes B, Arlt W, Stewart PM, Ride JP; ''Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1.''; Proc Natl Acad Sci U S A, 2011 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
11-Deoxycortisol | Metabolite | CHEBI:28324 (ChEBI) | |
11-HSD2 | GeneProduct | ENSG00000176387 (Ensembl) | |
11beta-HSD1 | GeneProduct | ENSG00000117594 (Ensembl) | |
17-beta-HSD3 | GeneProduct | ENSG00000130948 (Ensembl) | |
17-hydroxypregnenolone | Metabolite | CHEBI:28750 (ChEBI) | |
17-hydroxyprogesterone | Metabolite | CHEBI:17252 (ChEBI) | |
18-hydroxycorticosterone | Metabolite | CHEBI:16485 (ChEBI) | |
3-beta-HSD | GeneProduct | ENSG00000203859 (Ensembl) | |
5-alpha-Reductase2 | GeneProduct | ENSG00000277893 (Ensembl) | |
Aldosterone | Metabolite | CHEBI:27584 (ChEBI) | |
Androstenedione | Metabolite | CHEBI:16422 (ChEBI) | |
Cholesterol | Metabolite | CHEBI:16113 (ChEBI) | |
Corticosterone Methyl Oxidase | GeneProduct | ENSG00000179142 (Ensembl) | |
Corticosterone | Metabolite | CHEBI:16827 (ChEBI) | |
Cortisol | Metabolite | CHEBI:17650 (ChEBI) | |
Cortisone | Metabolite | CHEBI:16962 (ChEBI) | |
Cytochrome b5 | Protein | J3KNC7 (Uniprot-TrEMBL) | |
DHEA | Metabolite | CHEBI:28689 (ChEBI) | |
Deoxycorticosterone | Metabolite | CHEBI:16973 (ChEBI) | |
Dihydrotestosterone | Metabolite | CHEBI:16330 (ChEBI) | |
H6PD | GeneProduct | ENSG00000049239 (Ensembl) |
|
NADP+ | Metabolite | CHEBI:58349 (ChEBI) | |
NADPH | Metabolite | CHEBI:57783 (ChEBI) | |
Oestradiol | Metabolite | CHEBI:16469 (ChEBI) | |
P450Aro | GeneProduct | ENSG00000137869 (Ensembl) | |
P450c11 | GeneProduct | ENSG00000160882 (Ensembl) | |
P450c17 | GeneProduct | ENSG00000148795 (Ensembl) | |
P450c21 | GeneProduct | ENSG00000231852 (Ensembl) | |
P450scc | GeneProduct | ENSG00000140459 (Ensembl) |
|
POR | Protein | P16435 (Uniprot-TrEMBL) | |
Pregnenolone | Metabolite | CHEBI:16581 (ChEBI) | |
Progesterone | Metabolite | CHEBI:17026 (ChEBI) | |
STAR | GeneProduct | ENSG00000147465 (Ensembl) | |
Testosterone | Metabolite | CHEBI:17347 (ChEBI) |
Annotated Interactions
View all... |
Source | Target | Type | Database reference | Comment |
---|---|---|---|---|
11-Deoxycortisol | Cortisol | mim-conversion | RHEA:15630 (Rhea) | |
17-hydroxypregnenolone | 17-hydroxyprogesterone | mim-conversion | RHEA:24077 (Rhea) | |
17-hydroxypregnenolone | DHEA | mim-conversion | RHEA:50245 (Rhea) | |
17-hydroxyprogesterone | Androstenedione | mim-conversion | RHEA:14754 (Rhea) | |
18-hydroxycorticosterone | Aldosterone | mim-conversion | RHEA:11874 (Rhea) | |
Androstenedione | Testosterone | mim-conversion | RHEA:14983 (Rhea) | |
Cholesterol | Pregnenolone | mim-conversion | RHEA:35740 (Rhea) | |
Corticosterone | 18-hydroxycorticosterone | mim-conversion | RHEA:11873 (Rhea) | |
Cortisol | Cortisone | mim-conversion | RHEA:53117 (Rhea) | |
Cortisone | Cortisol | mim-conversion | RHEA:11390 (Rhea) | |
Deoxycorticosterone | Corticosterone | mim-conversion | RHEA:15630 (Rhea) | |
Pregnenolone | 17-hydroxypregnenolone | mim-conversion | RHEA:50237 (Rhea) | |
Pregnenolone | Progesterone | mim-conversion | RHEA:24077 (Rhea) | |
Progesterone | 17-hydroxyprogesterone | mim-conversion | RHEA:46309 (Rhea) | |
Testosterone | Dihydrotestosterone | mim-conversion | RHEA:54385 (Rhea) | |
Testosterone | Oestradiol | mim-conversion | RHEA:38192 (Rhea) |